Latest filing published 26 Sept 2023 for Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.), €5,352.
This profile gathers the share dealings of Timothy Steven Wach in Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.). We count 6 filings; the first trade dates from 8 May 2019 and the latest from 26 September 2023.
On the market, this insider has only ever bought: 3 purchases, €6,174 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €2,685. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 26 September 2023: a transaction of €5,352, in Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.). The latest purchase dates back some time: it was published 1,675 days ago, on 24 March 2022. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations